Patricia Griffin

A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial of d-Threo-Methylphenidate HCl in Brain Tumor Patients Receiving Radiation Therapy

J.M. Butler, L. Douglas Case, James N. Atkins et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 211 citations

Medicine, Pharmacology, Radiation Oncology +10

Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section

Jerome Dansereau, Arvind K. Joshi, Michael Helewa et al. · American Journal of Obstetrics and Gynecology · 1999 · 190 citations

Medicine, Gynecology, Obstetrics +17

Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial

Amanda R. Moraska, Amit Sood, Shaker R. Dakhil et al. · Journal of Clinical Oncology · 2010 · 172 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4

Robert C. Miller, David J. Schwartz, Jeff A. Sloan et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 168 citations

Medicine, Oncology, Radiation Oncology +12

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

Alessandro D. Santin, Michael W. Sill, D. Scott McMeekin et al. · Gynecologic Oncology · 2011 · 110 citations

Medicine, Gynecology, Oncology +13